Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
AstraZeneca
Hoffmann-La Roche
Avacta Life Sciences Ltd
University of Nebraska
Cancer Research UK
LigaChem Biosciences, Inc.
Merck Sharp & Dohme LLC
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
OncoC4, Inc.
Taproot Health
Convalife (Shanghai) Co., Ltd.
Universitair Ziekenhuis Brussel
Hoffmann-La Roche
Klus Pharma Inc.
Eastern Cooperative Oncology Group
Xencor, Inc.
MacroGenics
AIDS Malignancy Consortium
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
OHSU Knight Cancer Institute
University of Arizona
Otsuka Novel Products GmbH
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Roger Williams Medical Center